𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biocompatible oligochitosans as cationic modifiers of alginate/Ca microcapsules

✍ Scribed by G. Orive; A. Bartkowiak; S. Lisiecki; M. De Castro; R. M. Hernández; A. R. Gascòn; J. L. Pedraz


Book ID
102873885
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
824 KB
Volume
74B
Category
Article
ISSN
1552-4973

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In the past, it has been proven that by properly adjusting the molecular mass of the oligochitosan samples, it is possible to optimize the formation of rigid, biocompatible capsules with semipermeable membranes under physiological conditions. In this study, the feasibility of four oligochitosan samples, with varying molar masses (M~n~ in range 3–5 kDa), as biocompatible coatings of alginate/Ca capsules was investigated. By selection of appropriate depolymerization and purification methods we obtained oligochitosan samples that appeared to be noncytotoxic for C~2~C~12~ myoblasts and did not influence the mammalian cell metabolism especially in relative short time during the process of capsule formation. Furthermore, oligochitosans can be used as a tool to reduce the membrane cut‐off of the alginate capsules. However, such reduction, as well as mechanical resistance of formed microcapsules, depend on MM of the cationic polysaccharide and the chemical composition of the alginate (mannuronic/guluronic acid ratio). Here, we address that the use of low molar mass chitosan (< 5000 g/mol) permits the formation of mechanical stable capsules at physiological pH, which represents a strong advantage over other chitosan‐based chemistries. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2005


📜 SIMILAR VOLUMES


Biocompatibility and in vivo evaluation
✍ Maria De Castro; Gorka Orive; Rosa M. Hernández; Artur Bartkowiak; W. Brylak; Jo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

## Abstract The present article investigates the substitution of poly‐L‐lysine by two different oligochitosans as membrane‐coating capsule, and its effect on different functionality parameters of cell microencapsulation. To address this issue, initially the biocompatibility of the two types of olig

Improvement of the biocompatibility of a
✍ Aileen King; Berit Strand; Anne-Mari Rokstad; Bård Kulseng; Arne Andersson; Gudm 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract Alginate/poly‐L‐lysine(PLL)/alginate capsules are used widely for the microencapsulation of cells. Alginate consists of guluronic acid and mannuronic acid, the ratio and sequence of which affect the properties of the alginate. Using C5‐epimerases, mannuronic acid can be converted to gul